Asmod, Jilma M.
HRN: 11-61-02 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CO-AMOXICLAV 625MG (TAB)
12/28/2022
01/04/2023
PO
500mg
Q12
S/P NSVD; UTI
Waiting Final Action